Organigram Global Inc. (NASDAQ:OGI - Get Free Report)'s share price shot up 3.8% on Monday . The company traded as high as $1.39 and last traded at $1.38. 299,040 shares traded hands during mid-day trading, a decline of 52% from the average session volume of 618,505 shares. The stock had previously closed at $1.33.
Organigram Global Stock Performance
The company has a market capitalization of $193.67 million, a price-to-earnings ratio of 14.45 and a beta of 1.45. The firm's 50-day simple moving average is $1.40 and its 200-day simple moving average is $1.27.
Institutional Investors Weigh In On Organigram Global
Institutional investors have recently added to or reduced their stakes in the company. Renaissance Technologies LLC increased its position in shares of Organigram Global by 2.4% during the fourth quarter. Renaissance Technologies LLC now owns 914,648 shares of the company's stock valued at $1,473,000 after purchasing an additional 21,200 shares during the period. Arrowstreet Capital Limited Partnership acquired a new position in shares of Organigram Global in the fourth quarter valued at $1,153,000. Dimensional Fund Advisors LP raised its stake in shares of Organigram Global by 13.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 359,739 shares of the company's stock valued at $579,000 after purchasing an additional 43,721 shares in the last quarter. Baader Bank Aktiengesellschaft acquired a new position in shares of Organigram Global in the 2nd quarter valued at $338,000. Finally, Vontobel Holding Ltd. raised its stake in shares of Organigram Global by 140.5% in the 2nd quarter. Vontobel Holding Ltd. now owns 69,753 shares of the company's stock valued at $94,000 after buying an additional 40,753 shares in the last quarter. 34.63% of the stock is owned by institutional investors and hedge funds.
About Organigram Global
(
Get Free Report)
Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.
Featured Articles
Before you consider Organigram Global, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Organigram Global wasn't on the list.
While Organigram Global currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access